Assenagon Asset Management S.A. trimmed its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,996 shares of the company's stock after selling 2,823 shares during the period. Assenagon Asset Management S.A.'s holdings in Molina Healthcare were worth $7,857,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in MOH. State Street Corp lifted its stake in shares of Molina Healthcare by 0.5% in the 3rd quarter. State Street Corp now owns 2,614,311 shares of the company's stock valued at $900,787,000 after acquiring an additional 13,001 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Molina Healthcare by 22.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 470,932 shares of the company's stock worth $140,026,000 after acquiring an additional 84,929 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Molina Healthcare by 36.2% in the second quarter. AQR Capital Management LLC now owns 463,537 shares of the company's stock valued at $137,810,000 after acquiring an additional 123,121 shares during the period. Charles Schwab Investment Management Inc. raised its stake in shares of Molina Healthcare by 2.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 390,078 shares of the company's stock valued at $134,405,000 after acquiring an additional 10,030 shares during the last quarter. Finally, Swiss National Bank boosted its holdings in shares of Molina Healthcare by 0.3% during the third quarter. Swiss National Bank now owns 173,900 shares of the company's stock worth $59,919,000 after purchasing an additional 500 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have commented on MOH. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Robert W. Baird dropped their price target on Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating for the company in a research note on Thursday, October 24th. Barclays boosted their price objective on shares of Molina Healthcare from $359.00 to $372.00 and gave the company an "equal weight" rating in a research report on Friday, October 25th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, October 24th. Finally, Truist Financial reduced their price target on shares of Molina Healthcare from $400.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $359.18.
Check Out Our Latest Report on MOH
Molina Healthcare Stock Up 1.3 %
Shares of NYSE MOH traded up $3.76 on Monday, reaching $286.36. 838,441 shares of the company's stock traded hands, compared to its average volume of 426,981. The business's 50 day simple moving average is $296.84 and its two-hundred day simple moving average is $317.13. Molina Healthcare, Inc. has a 12 month low of $272.69 and a 12 month high of $423.92. The company has a market cap of $16.38 billion, a price-to-earnings ratio of 14.54, a price-to-earnings-growth ratio of 0.89 and a beta of 0.54. The company has a quick ratio of 1.55, a current ratio of 1.54 and a debt-to-equity ratio of 0.53.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.05. Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. The firm had revenue of $10.34 billion for the quarter, compared to analysts' expectations of $9.92 billion. During the same period in the prior year, the firm posted $5.05 earnings per share. The company's quarterly revenue was up 21.0% on a year-over-year basis. As a group, equities research analysts forecast that Molina Healthcare, Inc. will post 23.44 EPS for the current fiscal year.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.